🌟 Join Our Team! Exciting Opportunities Awaits! 🌟 Are you ready to take your career to the next level? We’re hiring and looking for passionate individuals to join our dynamic team! 🚀 🔍 Who We Are: At Scilex, we believe in fostering innovation, collaboration, and growth. Our team is dedicated to making a difference, and we want YOU to be a part of it! ✨ Why Join Us: • Collaborative and inclusive work environment • Opportunities for professional growth and development • Competitive salary and benefits 🌐 How to Apply: Visit our careers page - https://lnkd.in/gNdNGM5Z. Let’s build something amazing together! 🔗 Connect With Us: Follow us on LinkedIn for updates and news: https://lnkd.in/eJjsY378 Join us and be a part of something great. We can’t wait to see what you bring to the table! #Hiring #JobOpportunity #JoinOurTeam #CareerGrowth #Innovation
About us
SCILEX HOLDING COMPANY (Nasdaq: SCLX, “Scilex”), is dedicated to the development and commercialization of non-opioid pain management products. We are uncompromising in our focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. The company’s lead product ZTlido® (lidocaine topical system) 1.8%, is a marketed prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain. ZTlido® possesses novel delivery and adhesion technology designed to address many of the limitations of current prescription lidocaine patches by providing significantly improved adhesion and continuous pain relief. Click here for ZTLido’s Important Safety Information and US Prescribing Information. We have acquired two FDA approved non-opioid pain products, GLOPERBA® and ELYXYB®. GLOPERBA® is indicated for the prophylaxis of gout flares in adults. Elyxyb is indicated for the acute treatment of migraine with or without aura in adults. We launched ELYXYB® in the U.S. in April 2023 and are planning to commercialize GLOPERBA® in 2024. SCILEX is committed to harnessing the power of revolutionary delivery technologies designed to safely and effectively provide therapies to those who need them the most. Our three product candidates are (i) SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (“SEMDEXA™”), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain; (ii) SP-103 (lidocaine topical system) 5.4%, (“SP-103”), a next-generation, triple-strength formulation of ZTlido®, has recently completed a Phase 2 trial in acute lower back pain ; Scilex Pharmaceuticals and Semnur Pharmaceuticals are wholly-owned subsidiaries of Scilex Holding Company.
- Website
-
http://www.scilexholding.com
External link for Scilex Holding Company
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Palo Alto, California
- Type
- Public Company
- Founded
- 2019
- Specialties
- Pain and non-opioid
Locations
-
Primary
960 San Antonio Rd
100
Palo Alto, California 94303, US
-
960 San Antonio Road
Suite 100
Palo Alto, California 94303, US
Employees at Scilex Holding Company
Updates
-
Press Release: Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report https://lnkd.in/gM3vhhzz #pressrelease#ScilexPR
-
-
🌟 Introducing Our Top-Selling Product: ZTlido 🌟 We are thrilled to spotlight ZTlido, our revolutionary product that has been transforming lives and setting new standards in pain management. 💊 What is ZTlido? ZTlido is a lidocaine topical system designed to provide effective relief from pain associated with post-herpetic neuralgia. Its innovative design ensures that the patch stays securely in place, delivering continuous pain relief for up to 12 hours. 🔬 Why Choose ZTlido? • Advanced Adhesion: ZTlido’s superior adhesive properties mean it stays on through movement and perspiration, providing consistent pain relief. • Targeted Relief: Directly targets the affected area, minimizing systemic side effects. • Convenience: Easy to apply and remove, making it a user-friendly option for pain management. 📈 Proven Results: ZTlido has quickly become our top-selling product, trusted by healthcare professionals and patients alike for its effectiveness and reliability. Join the countless others who have experienced the benefits of ZTlido. Whether you’re a healthcare provider or someone seeking pain relief, ZTlido is here to help you live more comfortably and confidently. #ZTlido #PainManagement #HealthcareInnovation #TopSellingProduct #PainRelief #Healthcare
-
Press release: Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D. https://lnkd.in/gM3vhhzz #pressrelease#ScilexPR
-
-
Have you visited our Scilex Medical Information and Publications page on Scilex's website? - https://lnkd.in/g_rPDzUA As a valuable resource for all, especially healthcare professionals (HCPs), our Medical Information and Publications page offers a centralized location to access Scilex-related publications and critical medical information right at your fingertips. What You Can Find: • Latest Research: Stay up-to-date with the most recent studies and clinical trials involving Scilex products. • Educational Materials: Access detailed information and insights about our medical products and their applications. • Medical Resources: Explore a variety of resources to support your practice and enhance patient care. Visit our page today and discover a wealth of information designed to keep you informed and support your professional needs. #Scilex #MedicalInformation #Publications #HealthcareProfessionals #MedicalResearch #HCPResources
-
-
Dreaming of a career where you can make a real impact? We're urgently seeking for Territory Business Managers in multiple locations. Use your sales experience to help deliver life changing therapies to patients who need them. Apply today - https://lnkd.in/gNdNGM5Z #wearehiring#Scilexteam#salesmanagers
-
🚨 **Understanding Gout: A Common Yet Painful Condition** 🚨 Gout is a type of arthritis that can cause sudden, severe attacks of pain, swelling, redness, and tenderness in the joints, often the big toe. These flare-ups can be incredibly painful and debilitating, affecting quality of life. ✨ **Introducing Gloperba** ✨ Gloperba is an innovative solution designed to manage and prevent gout flare-ups. It works by reducing inflammation and pain, providing relief to those who suffer from this condition. Our goal is to help patients live more comfortably and with less disruption to their daily lives. 🔍 **Why Choose Gloperba?** - **Effective Relief:** Proven to reduce the frequency and severity of gout attacks. - **Easy to Use:** Convenient dosage form for better adherence. - **Trusted:** Recommended by healthcare professionals. Don’t let gout hold you back. Discover how Gloperba can help you reclaim your life from the grips of gout. For more information, visit our website - https://www.gloperba.com/ #Gout #Gloperba #Healthcare #PainRelief #ArthritisCare #Wellness
-
Press Release: Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region https://lnkd.in/gM3vhhzz #pressrelease#ScilexPR
-
-
Migraine disease can be debilitating, affecting daily life and productivity. Understanding triggers and finding effective treatments are essential for managing this condition. Introducing ELYXYB—a breakthrough in migraine treatment. Designed to provide rapid relief, ELYXYB can help you regain control and get back what matters most. Here are some tips for managing migraine disease: • Identify Triggers: Keep a diary to track potential triggers like certain foods, stress, or sleep patterns. • Stay Hydrated: Dehydration can trigger migraine attacks, so drink plenty of water. • Healthy Lifestyle: Regular exercise, a balanced diet, and sufficient sleep can help reduce the frequency of migraine attacks. • Stress Management: Practice relaxation techniques such as yoga, meditation, or deep breathing exercises. Consider talking to your healthcare provider about ELYXYB to see if it’s the right solution for you. Together, we can find ways to manage migraine disease more effectively. #MigraineAwareness #Health #Wellness #ELYXYB #MigraineRelief
-
Dreaming of a career where you can make a real impact? Exciting opportunities are available at Scilex! We're looking for talented individuals to join our team in the following roles: 1. **Territory Business Managers** 2. **Medical Science Liaison** 3. **Regional Business Director** 4. **Paralegal** 5. **Senior Data Analyst** **Why Join Us?** 🔹 Be part of a dynamic and innovative team 🔹 Competitive salaries and benefits 🔹 Opportunities for career growth and development 🔹 Collaborative and inclusive work environment **Who We're Looking For:** ✅ Experienced professionals in each respective field ✅ Strong communication and interpersonal skills ✅ Proven track record of success ✅ Passionate and driven individuals 📩 Apply now - https://lnkd.in/gNdNGM5Z or tag someone who might be interested! #Hiring #JobOpportunities #SalesManager #MedicalScienceLiaison #RegionalBusinessDirector #Paralegal #SeniorDataAnalyst #JoinOurTeam #CareerGrowth